Skip to main content
U.S. flag

An official website of the United States government

Laura Hauck

Laura Hauck
Biological Science Technician
Land and Watershed Management
3200 SW Jefferson Way
Corvallis, OR 97331
United States
Current Research
I am a highly trained molecular biologist with a passion for research and art. I am currently managing the Molecular Biology Laboratory for Plant Genomics in support of the Land and Watershed Management Program, a part of the Pacific Northwest Research station. The mission of the Pacific Northwest Research Station is to explore important biological, physical, and social considerations for forest ecosystems and reflects a strong science-management partnership that is vital to addressing society’s demands for forest goods and services. Work I have been involved with includes developing genomic markers to combat illegal logging and devloping assays that use environmental DNA to map species distributions in watersheds.
  • Oregon State University, PhD, Zoology, Cnidarian/Symbiodinium Symbiosis, 2007
  • Oregon State University, BS, Biology (marine option), Invasive Species, 2000
  • Northern Virginia Community College, Associates Of Applied Science, Science, 1996
Professional Experience
  • Biological Illustrator,  Liquid Vision Art Studio,  1996 - Current
    I am the owner of a small in-home business called “Liquid Vision Art Studio”. As an artist that specializes in wildlife, I have long enjoyed painting the aquatic realm in oils and watercolors; and have had my paintings displayed in several galleries. During the summer of 1999 I took a biological illustration course at the Oregon Institute of Marine Biology, Charleston, OR, in hopes of expanding my artistic endeavors. Since then I have been employed as a biological illustrator on multiple occasions through Oregon Sea Grant and have had my artwork published in two books, one flier, and an educational CD ROM. Many of these publications were designed to promote awareness of marine topics for the general public.
  • Research Associate,  Department of Biomedical Sciences, College of Veterinary Medicine, Oregon State University,  2013 - 2014
    I conducted research in support of multiple contracts while a part of the Department of Biomedical Sciences. I helped develop the baseline methods for a project evaluating microbiome shifts and behavioral changes resulting from shifts in diet. In doing this I assisted with behavioral assessments of mice, and designed the approach and executed the pyrosequencing of the mouse microbiome which included conjugate primer design, amplification and post-sequencing command line bioinformatic analysis of pyrosequencing data. Other work included analysis of industrial samples for microbial infection, and anti-microbial properties against established biofilms. Once isolated, contaminating micro-organisms were identified by molecular techniques. I also performed scientific research to evaluate novel therapies (cochleate and liposome formulations of ciprofloxacin) in the mouse model of Mycobacterium avium disease. This research included conducting BSL-2 infected animal studies to assess the effectiveness of the novel delivery methods, determination of bacterial load post-treatment, and analysis and write-up of resultant data.
  • Research Scientists/Control Account Manager,  AviBiopharma (also known as Sarepta Therapeutics),  2008 - 2012
    As a Research Scientist I contributed to the development of Intellectual Property (I.P.) on a number of infectious disease projects as I helped develop RNA-based therapeutics. My efforts included early discovery research and target validation, as well as immunotoxicity testing of drug compounds utilizing a wide variety of molecular techniques to analyze the effectiveness, mechanism of action and toxicity of anti-viral pharmaceutical phosphorodiamidate morpholino oligomers (PMOs) targeting the virus or host factors thought to be involved in viral pathogenesis and inflammation. I also served as the Control Account Manager (CAM) for the Research and Innovation (R&I) portions of a contract exceeding $200 million. The contract was with Transformational Medical Technologies program (TMT) of the Defense Threat Reduction Agency, a part of the U.S. Department of Defense, and is for the development of antiviral agents for Marburg and Ebola viruses. As the CAM for R&I I was responsible for assisting in the design of efficacy studies being conducted, protocol development and quality control, scheduling of all studies performed at the Contract Research Organizations (CROs), managing the day to day efforts in support of the contract, and maintaining the scope, schedule and cost of the R&I portion of the contract.
  • NSF Pre-Doctoral Fellow,  Oregon State University,  2001 - 2003
    Recipient of an NSF Pre-Doctoral Fellowship.
  • Corporal,  United States Marine Corps,  1991 - 1994
    Fighter for good in the world.
Other Publications